Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia
Naoya MasumoriDepartment of Urology, Sapporo Medical University School of Medicine, Sapporo, JapanAbstract: Naftopidil, approved only in Japan, is an α1-adrenergic receptor antagonist (α1-blocker) used to treat lower urinary tract symptoms (LUTS) suggestive of benign prostatic hy...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2011-06-01
|
| Sarja: | Therapeutics and Clinical Risk Management |
| Linkit: | http://www.dovepress.com/naftopidil-for-the-treatment-of-urinary-symptoms-in-patients-with-beni-a7716 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|